Lumexa Imaging (LMRI) reported Q1 adjusted earnings late Tuesday of $0.18 per diluted share, up from $0.04 a year earlier.

Revenue for the quarter ended March 31 was $252.5 million, up from $245 million a year earlier.

Analysts surveyed by FactSet expected $249.5 million.

For full-year 2026, the company still expects adjusted EPS of $0.71 to $0.77 on revenue of $1.05 billion to $1.10 billion. Analysts surveyed by FactSet expect revenue of $1.06 billion.